DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features.
M. S. Mosella, T. S. Sabedot, T. C. Silva, T. M. Malta, F. D. Segato, K. P. Asmaro, M. Wells, A. Mukherjee, L. M. Poisson, J. Snyder, A. C. deCarvalho, T. Walbert, T. Aho, S. Kalkanis, P. C. Elias, , A. V. Castro
This paper identifies and validates DNA methylation signatures that classify sporadic pituitary tumors based on clinicopathological features and adenohypophyseal cell lineages.
Neuro-Oncology · Feb 25, 2021Peer-reviewedCancer Biology